Can Fin Homes Limited (NSE:CANFINHOME)
India · Delayed Price · Currency is INR 740.35
-11.60 (-1.54%)
Aug 1, 2025, 3:30 PM IST
Theseus Pharmaceuticals Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Cash & Equivalents | - | 10.59 | 7.58 | 18.76 | 26.99 | 7.93 | Upgrade |
Long-Term Investments | - | 23,740 | 14,590 | 14,590 | 11,260 | 496.04 | Upgrade |
Loans & Lease Receivables | - | 376,964 | 345,531 | 311,933 | 263,781 | 218,915 | Upgrade |
Other Receivables | - | 46.89 | 42.48 | 80.48 | 34.2 | 21.64 | Upgrade |
Property, Plant & Equipment | - | 503.45 | 526.19 | 454.04 | 346.2 | 378.24 | Upgrade |
Restricted Cash | - | 3,000 | 4,500 | 3,000 | 3,000 | - | Upgrade |
Other Current Assets | - | 118.79 | 110.85 | 106.53 | 250.37 | 423.38 | Upgrade |
Long-Term Deferred Tax Assets | - | 693.53 | 658.66 | 484.3 | 477.26 | 454.55 | Upgrade |
Other Long-Term Assets | - | 4,596 | 4,170 | 37.22 | 268.06 | 40.86 | Upgrade |
Total Assets | - | 409,673 | 370,137 | 330,705 | 279,443 | 220,737 | Upgrade |
Interest Bearing Deposits | - | 1,935 | 2,321 | 4,471 | 5,050 | 4,542 | Upgrade |
Total Deposits | - | 1,935 | 2,321 | 4,471 | 5,050 | 4,542 | Upgrade |
Accounts Payable | - | 60.76 | 47.04 | 80.49 | 55.52 | 43.26 | Upgrade |
Accrued Expenses | - | 114.09 | 73.72 | 41.04 | 33.5 | 720.45 | Upgrade |
Short-Term Debt | - | 73,576 | 69,829 | 60,022 | 61,167 | 57,692 | Upgrade |
Long-Term Debt | - | 277,437 | 248,877 | 228,634 | 181,644 | 130,812 | Upgrade |
Long-Term Leases | - | 344.19 | 469.54 | 388.05 | 321.88 | 361.7 | Upgrade |
Current Income Taxes Payable | - | 4,681 | 4,282 | 60.48 | 4.19 | 4.19 | Upgrade |
Other Current Liabilities | - | 207.5 | 141.59 | 134 | 183.29 | 86.05 | Upgrade |
Pension & Post-Retirement Benefits | - | 343.78 | 341.54 | 277.27 | 239.62 | 300.15 | Upgrade |
Other Long-Term Liabilities | - | 219.43 | 241.61 | 57.46 | 10.86 | 19.79 | Upgrade |
Total Liabilities | - | 358,998 | 326,698 | 294,232 | 248,777 | 194,639 | Upgrade |
Common Stock | - | 266.31 | 266.31 | 266.31 | 266.31 | 266.31 | Upgrade |
Additional Paid-In Capital | - | 2,730 | 2,730 | 2,730 | 2,730 | 2,730 | Upgrade |
Retained Earnings | - | 47,679 | 40,442 | 33,477 | 27,670 | 23,102 | Upgrade |
Comprehensive Income & Other | - | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade |
Shareholders' Equity | 50,675 | 50,675 | 43,439 | 36,473 | 30,666 | 26,098 | Upgrade |
Total Liabilities & Equity | - | 409,673 | 370,137 | 330,705 | 279,443 | 220,737 | Upgrade |
Total Debt | 351,544 | 351,358 | 319,176 | 289,044 | 243,134 | 188,866 | Upgrade |
Net Cash (Debt) | -348,467 | -351,347 | -319,168 | -289,025 | -243,107 | -188,858 | Upgrade |
Net Cash Per Share | -2616.88 | -2638.66 | -2396.99 | -2170.61 | -1825.75 | -1418.34 | Upgrade |
Filing Date Shares Outstanding | 133.18 | 133.15 | 133.23 | 133.15 | 133.15 | 133.15 | Upgrade |
Total Common Shares Outstanding | 133.18 | 133.15 | 133.23 | 133.15 | 133.15 | 133.15 | Upgrade |
Working Capital | - | 299,487 | 273,423 | 250,264 | 200,532 | 156,222 | Upgrade |
Book Value Per Share | 380.63 | 380.57 | 326.05 | 273.91 | 230.31 | 196.00 | Upgrade |
Tangible Book Value | 50,675 | 50,675 | 43,439 | 36,473 | 30,666 | 26,098 | Upgrade |
Tangible Book Value Per Share | 380.63 | 380.57 | 326.05 | 273.91 | 230.31 | 196.00 | Upgrade |
Updated Jan 18, 2025. Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.